Skip to content

US · CTVA · AGRICULTURAL INPUTS

Corteva, Inc. (CTVA) intrinsic value and stock valuation

$7.89as of 2026-11-21 · Mkt cap 51.39B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Corteva, Inc. DCF and intrinsic value

InvestorsCraft values CTVA with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from CTVA’s statements →

Corteva, Inc. Graham Number

Graham Number: $36.03d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Agricultural Inputs Indianapolis, IN 46268 corteva.com

How the business is doing

Fiscal 2016–2025, USD

Revenue
$17.4B+4.1% 5y CAGRd
20162025
Net income
$1.09B+9.9% 5y CAGRd
20162025
Free cash flow
$2.82B+12.1% 5y CAGRd
20162025
Total equity
$24.4B-0.5% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2016–2025, USD
20252024202320222021
Revenue$17.4B$16.9B$17.2B$17.5B$15.7B
Operating income$2.62B$2.1B$2.11B$1.93B$1.32B
Net income$1.09B$907M$735M$1.15B$1.76B
EPSd$1.61M$1.3M$1.03M$1.58M$2.37M
Operating cash flow$3.41B$2.15B$1.77B$872M$2.73B
Capital expenditure-$-591M-$-597M-$-595M-$-605M-$-573M
Free cash flow$2.82B$1.55B$1.17B$267M$2.15B
Total assets$42.8B$40.8B$43B$42.6B$42.3B
Total debt$2.58B$2.7B$2.49B$1.31B$1.12B
Net debt-$-1.94B-$-403M-$-155M-$-1.88B-$-3.34B
Total equity$24.4B$24B$25.3B$25.5B$25.6B
Cash and short-term investments$4.53B$3.17B$2.74B$3.32B$4.55B
Income statement
20252024202320222021
Revenue$17.4B$16.9B$17.2B$17.5B$15.7B
Cost of revenue$9.17B$9.53B$9.92B$10.4B$9.22B
Gross profit$8.23B$7.38B$7.31B$7.02B$6.44B
Research and development expenses$1.47B$1.4B$1.34B$1.22B$1.19B
Selling, general and administrative expenses$3.49B$3.2B$3.18B$3.17B$3.21B
Other expenses$644M$685M$683M$702M$722M
Operating expenses$5.61B$5.28B$5.2B$5.09B$5.12B
Cost and expenses$14.8B$14.8B$15.1B$15.5B$14.3B
Interest income$136M$132M$283M$124M$77M
Interest expense$180M$233M$233M$79M$30M
Depreciation and amortization$1.2B$1.23B$1.21B$1.22B$1.24B
Ebitda$3.07B$2.74B$2.54B$2.73B$3.62B
Operating income$2.62B$2.1B$2.11B$1.93B$1.32B
Total other income/expenses, net-$-931M-$-821M-$-1.02B-$-502M$1.03B
Income before tax$1.69B$1.28B$1.09B$1.43B$2.35B
Income tax expense$484M$412M$152M$210M$524M
Net income$1.09B$907M$735M$1.15B$1.76B
Weighted average shares outstanding$680M$693.7M$709M$720.8M$735.9M
Weighted average diluted shares outstanding$681.4M$696M$711.9M$724.5M$741.6M
Balance sheet
20252024202320222021
Cash and short-term investments$4.53B$3.17B$2.74B$3.32B$4.55B
Net receivables$6.37B$5.68B$5.49B$5.7B$4.81B
Inventory$5.67B$5.43B$6.9B$6.81B$5.18B
Total current assets$17.3B$15.1B$16.3B$16.8B$15.5B
Property, plant and equipment, net$4.22B$4.1B$4.29B$4.25B$4.33B
Goodwill and intangible assets$18.8B$19.3B$20.2B$19.3B$20.2B
Long-term investments$160M$134M$115M$102M$76M
Total non-current assets$25.5B$25.7B$26.7B$25.8B$26.8B
Total assets$42.8B$40.8B$43B$42.6B$42.3B
Accounts payable$4.4B$4.04B$4.28B$4.9B$4.13B
Short-term debt$894M$750M$198M$24M$17M
Deferred revenue$3.58B$3.29B$3.41B$3.39B$3.2B
Total current liabilities$12.1B$10.4B$10.4B$10.7B$9.56B
Long-term debt$1.69B$1.95B$2.29B$1.28B$1.1B
Deferred revenue, non-current$0.00$0.00$0.00$0.00-$-3M
Total non-current liabilities$6.33B$6.41B$7.31B$6.33B$7.16B
Capital lease obligations$0.00$0.00$1M$3M$3M
Total liabilities$18.5B$16.8B$17.7B$17.1B$16.7B
Common stock$7M$7M$7M$7M$7M
Retained earnings-$-67M$55M-$-41M$250M$524M
Accumulated other comprehensive income (loss)-$-2.8B-$-3.47B-$-2.68B-$-2.81B-$-2.9B
Total equity$24.4B$24B$25.3B$25.5B$25.6B
Total investments$169M$197M$213M$226M$162M
Total debt$2.58B$2.7B$2.49B$1.31B$1.12B
Net debt-$-1.94B-$-403M-$-155M-$-1.88B-$-3.34B
Cash flow statement
20252024202320222021
Net income$1.11B$863M$941M$1.21B$1.82B
Depreciation and amortization$1.2B$1.23B$1.21B$1.22B$1.24B
Stock-based compensation$0.00$0.00$0.00$55M$0.00
Change in working capital$540M-$-92M-$-786M-$-1.55B$656M
Accounts receivable-$-261M-$-705M$358M-$-997M-$-113M
Inventory-$-35M$1.11B$57M-$-1.72B-$-422M
Accounts payable$231M-$-115M-$-663M$807M$524M
Net cash provided by operating activities$3.41B$2.15B$1.77B$872M$2.73B
Investments in property, plant and equipment-$-591M-$-597M-$-595M-$-605M-$-573M
Acquisitions, net-$-20M-$-7M-$-1.46B-$-12M-$-4M
Net cash used for investing activities-$-543M-$-589M-$-1.99B-$-632M-$-362M
Common stock issued$88M$0.00$0.00$0.00$0.00
Common stock repurchased-$-1.07B-$-1.01B-$-756M-$-1B-$-950M
Dividends paid-$-475M-$-458M-$-439M-$-418M-$-397M
Net cash used for financing activities-$-1.64B-$-1.2B-$-99M-$-1.18B-$-1.27B
Net change in cash$1.1B$264M-$-460M-$-1.22B$963M
Cash at end of period$4.52B$3.42B$3.16B$3.62B$4.84B
Operating cash flow$3.41B$2.15B$1.77B$872M$2.73B
Capital expenditure-$-591M-$-597M-$-595M-$-605M-$-573M
Free cash flow$2.82B$1.55B$1.17B$267M$2.15B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Corteva, Inc.

        Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.

        CEO
        Charles Magro
        Employees
        21.5K
        Beta
        0.56

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Corteva, Inc. (CTVA)?

        Corteva, Inc. (CTVA) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CTVA undervalued?

        CTVA trades at a price of $7.89 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.